American Portfolios Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $16.9K | Hold |
75
| – | – | ﹤0.01% | 2274 |
|
2022
Q2 | $14.2K | Sell |
75
-50
| -40% | -$9.45K | ﹤0.01% | 2407 |
|
2022
Q1 | $31.1K | Buy |
125
+50
| +67% | +$12.5K | ﹤0.01% | 2129 |
|
2021
Q4 | $11.7K | Hold |
75
| – | – | ﹤0.01% | 2565 |
|
2021
Q3 | $15K | Hold |
75
| – | – | ﹤0.01% | 2405 |
|
2021
Q2 | $19.2K | Hold |
75
| – | – | ﹤0.01% | 2243 |
|
2021
Q1 | $19.9K | Hold |
75
| – | – | ﹤0.01% | 2074 |
|
2020
Q4 | $27.7K | Hold |
75
| – | – | ﹤0.01% | 1670 |
|
2020
Q3 | $18.3K | Buy |
75
+51
| +213% | +$12.5K | ﹤0.01% | 1731 |
|
2020
Q2 | $6.96K | Buy |
24
+4
| +20% | +$1.16K | ﹤0.01% | 2092 |
|
2020
Q1 | $4.08K | Hold |
20
| – | – | ﹤0.01% | 2175 |
|
2019
Q4 | $8.94K | Hold |
20
| – | – | ﹤0.01% | 2043 |
|
2019
Q3 | $6.15K | Buy |
20
+13
| +186% | +$4K | ﹤0.01% | 2116 |
|
2019
Q2 | $2.12K | Hold |
7
| – | – | ﹤0.01% | 2461 |
|
2019
Q1 | $2.8K | Hold |
7
| – | – | ﹤0.01% | 2280 |
|
2018
Q4 | $2.03K | Hold |
7
| – | – | ﹤0.01% | 2135 |
|
2018
Q3 | $2.4K | Buy |
+7
| New | +$2.4K | ﹤0.01% | 2195 |
|